HMG CoA Reductase Inhibitors
- 1 January 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (Supplement), 83-86
- https://doi.org/10.2165/00003495-198800363-00017
Abstract
Lovastatin and simvastatin are the 2 best-known members of the class of hypolipidaemic agents known as HMG CoA reductase inhibitors. Clinical experience with lovastatin includes over 5000 patients,...Keywords
This publication has 11 references indexed in Scilit:
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL RESULTS .2. THE RELATIONSHIP OF REDUCTION IN INCIDENCE OF CORONARY HEART-DISEASE TO CHOLESTEROL LOWERING1984
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A ReductaseEuropean Journal of Biochemistry, 1977
- Probability of Middle-Aged Men Developing Coronary Heart Disease in Five YearsCirculation, 1972
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971
- Cataracts produced by triparanol. (MER-29).1967
- EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN*Journal of Clinical Investigation, 1961